Comparative Pharmacology
Head-to-head clinical analysis: OPHTHAINE versus OPHTHETIC.
Peer-Reviewed Evidence
Head-to-head clinical analysis: OPHTHAINE versus OPHTHETIC.
OPHTHAINE vs OPHTHETIC
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Local anesthetic that blocks sodium ion channels in neuronal membranes, preventing initiation and conduction of nerve impulses, thereby producing local anesthesia.
Ophthalmic anesthetic; blocks sodium ion channels in nerve cell membranes, inhibiting depolarization and conduction of nerve impulses.
1-2 drops of 0.5% solution to the affected eye(s) as a single dose prior to tonometry or minor procedures; can be repeated in 5-10 minutes if needed.
1-2 drops of 0.5% solution into the affected eye(s) every 5-10 minutes for 3-5 doses prior to procedures; or 1-2 drops of 0.5% solution every 5-10 minutes for 2-3 doses for minor procedures.
None Documented
None Documented
Terminal elimination half-life is approximately 10-15 minutes, reflecting rapid hydrolysis by esterases, resulting in very short systemic exposure.
Terminal elimination half-life is 2.5 to 3 hours (prolonged in renal impairment).
Primarily metabolized by plasma esterases; renal excretion of metabolites accounts for >90% of elimination, with <5% excreted unchanged in urine. Biliary/fecal elimination is negligible.
Primarily renal excretion of unchanged drug and metabolites; ~80% eliminated in urine within 24 hours, with minor biliary/fecal excretion (<5%).
Category C
Category C
Ophthalmic Anesthetic (Local)
Ophthalmic Anesthetic (Local)